{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:56:47Z","timestamp":1793480207988,"version":"4.5.0"},"reference-count":110,"publisher":"American Medical Association (AMA)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,11,12]]},"abstract":"<jats:sec id=\"ab-jrv240021-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>More than 3.5 million people worldwide and 540\u202f000 individuals in the US receive maintenance hemodialysis or peritoneal dialysis for the treatment of chronic kidney failure. The 5-year survival rate is approximately 40% after initiation of maintenance dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv240021-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>\n                      Hemodialysis and peritoneal dialysis remove metabolic waste and excess body water and rebalance electrolytes to sustain life. There is no recommended estimated glomerular filtration rate (eGFR) threshold for initiating dialysis, and patient-clinician shared decision-making should help determine when to initiate dialysis. Persistent signs and symptoms of uremia (eg, nausea, fatigue) and volume overload (eg, dyspnea, peripheral edema), worsening eGFR, metabolic acidosis, and hyperkalemia inform the timing of therapy initiation. A randomized clinical trial reported no mortality benefit to starting dialysis at higher eGFR (10-14 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ) vs lower eGFR (5-7 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ) levels. Observational data suggested no differences in 5-year mortality with use of hemodialysis vs peritoneal dialysis. Cardiovascular (eg, arrhythmias, cardiac arrest) and infection-related complications of maintenance dialysis are common. In the US, hemodialysis catheter\u2013related bloodstream infections occur at a rate of 1.1 to 5.5 episodes per 1000 catheter-days and affect approximately 50% of patients within 6 months of catheter placement. Peritonitis occurs at a rate of 0.26 episodes per patient-year and affects about 30% of individuals in the first year of peritoneal dialysis therapy. Chronic kidney failure\u2013related systemic complications, such as anemia, hyperphosphatemia, hypocalcemia, and hypertension, often require pharmacologic treatment. Hypotension during dialysis, refractory symptoms (eg, muscle cramps, itching), and malfunction of dialysis access can interfere with delivery of dialysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv240021-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In 2021, more than 540\u202f000 patients in the US received maintenance hemodialysis or peritoneal dialysis for treatment of chronic kidney failure. Five-year survival rate after initiation of maintenance dialysis is approximately 40%, and the mortality rate is similar with hemodialysis and peritoneal dialysis. Decisions about dialysis initiation timing and modality are influenced by patient symptoms, laboratory trajectories, patient preferences, and therapy cost and availability and should include shared decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2024.16338","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T11:30:25Z","timestamp":1727868625000},"page":"1559","source":"Crossref","is-referenced-by-count":202,"title":["Dialysis for Chronic Kidney Failure"],"prefix":"10.1001","volume":"332","author":[{"given":"Jennifer E.","family":"Flythe","sequence":"first","affiliation":[{"name":"University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Watnick","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Washington School of Medicine, Seattle"},{"name":"Section of Nephrology, Seattle VA Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"jrv240021r1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/ndt\/gfac165","article-title":"Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study.","volume":"38","author":"Huijben","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"9981","key":"jrv240021r2","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review.","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"jrv240021r4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.ajkd.2021.02.327","article-title":"Burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-center hemodialysis: findings from the DOPPS Program.","volume":"78","author":"Brown","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"jrv240021r5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/kisup.2012.37","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"jrv240021r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"issue":"6","key":"jrv240021r7","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1161\/HYP.0000000000000230","article-title":"Hypertension in patients treated with in-center maintenance hemodialysis: current evidence and future opportunities: a scientific statement from the American Heart Association.","volume":"80","author":"Bansal","year":"2023","journal-title":"Hypertension"},{"issue":"13","key":"jrv240021r8","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.3390\/jcm11133759","article-title":"Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin.","volume":"11","author":"Campo","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"jrv240021r9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ki.2015.110","article-title":"Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.","volume":"88","author":"Davison","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"jrv240021r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003954","article-title":"Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis.","volume":"19","author":"Fletcher","year":"2022","journal-title":"PLoS Med"},{"issue":"1","key":"jrv240021r11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review.","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"jrv240021r12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.ajkd.2017.08.019","article-title":"Patient-reported outcome measures for fatigue in patients on hemodialysis: a systematic review.","volume":"71","author":"Ju","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"jrv240021r13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1053\/j.ajkd.2015.12.028","article-title":"Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis.","volume":"67","author":"O\u2019Lone","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv240021r14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12882-023-03184-4","article-title":"Update of dialysis initiation timing in end stage kidney disease patients: is it a resolved question? A systematic literature review.","volume":"24","author":"Jia","year":"2023","journal-title":"BMC Nephrol"},{"issue":"5","key":"jrv240021r15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.ajkd.2014.11.031","article-title":"Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.","volume":"66","author":"Slinin","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"jrv240021r16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","article-title":"KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update.","volume":"66","author":"Daugirdas","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"jrv240021r17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJMoa1000552","article-title":"A randomized, controlled trial of early versus late initiation of dialysis.","volume":"363","author":"Cooper","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv240021r18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis.","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"jrv240021r19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","article-title":"Effect of hemodiafiltration or hemodialysis on mortality in kidney failure.","volume":"389","author":"Blankestijn","year":"2023","journal-title":"N Engl J Med"},{"key":"jrv240021r20","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117749531","article-title":"Mortality and hospitalizations in intensive dialysis: a systematic review and meta-analysis.","volume":"5","author":"Mathew","year":"2018","journal-title":"Can J Kidney Health Dis"},{"issue":"10","key":"jrv240021r21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ki.2011.213","article-title":"The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.","volume":"80","author":"Rocco","year":"2011","journal-title":"Kidney Int"},{"issue":"24","key":"jrv240021r22","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week.","volume":"363","author":"Chertow","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"jrv240021r23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"jrv240021r24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12882-015-0175-5","article-title":"Impact of initial dialysis modality on mortality: a propensity-matched study.","volume":"16","author":"Waldum-Grevbo","year":"2015","journal-title":"BMC Nephrol"},{"issue":"4","key":"jrv240021r25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3747\/pdi.2018.00227","article-title":"Comparison of cardiovascular outcomes by dialysis modality: a systematic review and meta-analysis.","volume":"39","author":"Lozier","year":"2019","journal-title":"Perit Dial Int"},{"issue":"s4","key":"jrv240021r26","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1111\/j.1440-1797.2005.00465_3.x","article-title":"Selection of patients for automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis.","volume":"10","author":"Johnson","year":"2005","journal-title":"Nephrology (Carlton)"},{"issue":"19","key":"jrv240021r27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra2100152","article-title":"Peritoneal dialysis.","volume":"385","author":"Teitelbaum","year":"2021","journal-title":"N Engl J Med"},{"key":"jrv240021r28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12913-015-1166-8","article-title":"The cost of dialysis in low and middle-income countries: a systematic review.","volume":"15","author":"Mushi","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"jrv240021r29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0896860819895364","article-title":"International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis.","volume":"40","author":"Brown","year":"2020","journal-title":"Perit Dial Int"},{"issue":"12","key":"jrv240021r30","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/ndt\/gfz278","article-title":"Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis.","volume":"35","author":"Elsayed","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"jrv240021r32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0896860820918710","article-title":"Urgent-start peritoneal dialysis in chronic kidney disease patients: a systematic review and meta-analysis compared with planned peritoneal dialysis and with urgent-start hemodialysis.","volume":"41","author":"Xieyi","year":"2021","journal-title":"Perit Dial Int"},{"issue":"10","key":"jrv240021r33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/nep.14042","article-title":"Peritoneal dialysis first policy in Hong Kong for 35 years: global impact.","volume":"27","author":"Li","year":"2022","journal-title":"Nephrology (Carlton)"},{"issue":"15","key":"jrv240021r34","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2024.0535","article-title":"Arteriovenous access for hemodialysis: a review.","volume":"331","author":"Lok","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"jrv240021r35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"2019 Update.","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"jrv240021r36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.ajkd.2019.08.001","article-title":"surgeon characteristics and dialysis vascular access outcomes in the United States: a retrospective cohort study.","volume":"75","author":"Shahinian","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"jrv240021r37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/ASN.2012070643","article-title":"Associations between hemodialysis access type and clinical outcomes: a systematic review.","volume":"24","author":"Ravani","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"jrv240021r38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.kint.2022.07.012","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease.","volume":"102","author":"Martin","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"jrv240021r39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12882-019-1529-1","article-title":"Clinical practice guideline management of blood borne viruses within the haemodialysis unit.","volume":"20","author":"Garthwaite","year":"2019","journal-title":"BMC Nephrol"},{"issue":"3","key":"jrv240021r40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.kint.2023.05.019","article-title":"Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"104","author":"Mehrotra","year":"2023","journal-title":"Kidney Int"},{"issue":"1","key":"jrv240021r41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ekir.2020.10.020","article-title":"A systematic review of the incidence of arrhythmias in hemodialysis patients undergoing long-term monitoring with implantable loop recorders.","volume":"6","author":"Roberts","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"2","key":"jrv240021r42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1053\/j.ajkd.2022.06.011","article-title":"Calciphylaxis and kidney disease: a review.","volume":"81","author":"Gallo Marin","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"jrv240021r43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/ndt\/gfz116","article-title":"New-onset glucose disorders in peritoneal dialysis patients: a meta-analysis and systematic review.","volume":"35","author":"Xue","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"jrv240021r44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/j.ajkd.2023.04.005","article-title":"Peritoneal dialysis-related drain pain and patient and treatment characteristics: findings from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).","volume":"82","author":"Aga","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"jrv240021r45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/1744-9987.13917","article-title":"Prevalence and outcome of abdominal wall hernia in patients with end-stage renal disease on peritoneal dialysis.","volume":"27","author":"Girimaji","year":"2023","journal-title":"Ther Apher Dial"},{"issue":"3","key":"jrv240021r46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3747\/pdi.2013.00139","article-title":"The risk factors and the impact of hernia development on technique survival in peritoneal dialysis patients: a population-based cohort study.","volume":"35","author":"Yang","year":"2015","journal-title":"Perit Dial Int"},{"issue":"4","key":"jrv240021r47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3747\/pdi.2017.00018","article-title":"Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis - position paper for ISPD: 2017 update.","volume":"37","author":"Brown","year":"2017","journal-title":"Perit Dial Int"},{"issue":"9","key":"jrv240021r48","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jvir.2013.05.034","article-title":"Natural history of tunneled dialysis catheters placed for hemodialysis initiation.","volume":"24","author":"Shingarev","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"jrv240021r49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2019.09.016","article-title":"Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).","volume":"76","author":"Perl","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv240021r50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0896860821996096","article-title":"A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases.","volume":"42","author":"Marshall","year":"2022","journal-title":"Perit Dial Int"},{"issue":"5","key":"jrv240021r51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1053\/j.ajkd.2014.04.025","article-title":"First-year outcomes of incident peritoneal dialysis patients in the United States.","volume":"64","author":"Pulliam","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"jrv240021r52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"issue":"21","key":"jrv240021r53","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1001\/jama.2022.21289","article-title":"Peritoneal fluid analysis in peritoneal dialysis-associated peritonitis.","volume":"328","author":"Perl","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"jrv240021r54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/08968608231172740","article-title":"ISPD catheter-related infection recommendations: 2023 update.","volume":"43","author":"Chow","year":"2023","journal-title":"Perit Dial Int"},{"issue":"2","key":"jrv240021r55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2215\/CJN.05260516","article-title":"Diagnosis, treatment, and prevention of hemodialysis emergencies.","volume":"12","author":"Saha","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"jrv240021r56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000500877","article-title":"The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis.","volume":"49","author":"Kuipers","year":"2019","journal-title":"Am J Nephrol"},{"issue":"3","key":"jrv240021r57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1681\/ASN.2014020222","article-title":"Association of mortality risk with various definitions of intradialytic hypotension.","volume":"26","author":"Flythe","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"jrv240021r58","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2020.01.046","article-title":"Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"97","author":"Flythe","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"jrv240021r59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3747\/pdi.2014.00279","article-title":"ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I\u2014assessment and management of various cardiovascular risk factors.","volume":"35","author":"Wang","year":"2015","journal-title":"Perit Dial Int"},{"issue":"2","key":"jrv240021r60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/0896860819893813","article-title":"Quantifying the risk of insertion-related peritoneal dialysis catheter complications following laparoscopic placement: results from the North American PD Catheter Registry.","volume":"40","author":"Oliver","year":"2020","journal-title":"Perit Dial Int"},{"issue":"5","key":"jrv240021r61","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3747\/pdi.2018.00232","article-title":"Creating and maintaining optimal peritoneal dialysis access in the adult patient: 2019 update.","volume":"39","author":"Crabtree","year":"2019","journal-title":"Perit Dial Int"},{"issue":"5","key":"jrv240021r62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis.","volume":"380","author":"Macdougall","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv240021r63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","article-title":"Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"104","author":"Ku","year":"2023","journal-title":"Kidney Int"},{"issue":"11","key":"jrv240021r64","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis.","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv240021r65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010590.pub3","article-title":"Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.","volume":"2","author":"Chung","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv240021r66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2215\/CJN.01541005","article-title":"Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.","volume":"1","author":"Singh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"jrv240021r67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007554.pub2","article-title":"Biocompatible dialysis fluids for peritoneal dialysis.","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"jrv240021r68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2215\/CJN.07480618","article-title":"Assessment and management of hypertension among patients on peritoneal dialysis.","volume":"14","author":"Vaios","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"jrv240021r70","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","article-title":"Hyperlipidemia in patients with chronic renal disease.","volume":"32","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"jrv240021r71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/M23-1794","article-title":"Effectiveness of existing insomnia therapies for patients undergoing hemodialysis: a randomized clinical trial.","volume":"177","author":"Mehrotra","year":"2024","journal-title":"Ann Intern Med"},{"issue":"5","key":"jrv240021r72","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ekir.2020.01.006","article-title":"Randomized controlled trial of difelikefalin for chronic pruritus in hemodialysis patients.","volume":"5","author":"Fishbane","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"12","key":"jrv240021r73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004542.pub3","article-title":"Psychosocial interventions for preventing and treating depression in dialysis patients.","volume":"12","author":"Natale","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jrv240021r74","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/ki.2013.147","article-title":"Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism.","volume":"84","author":"Ikizler","year":"2013","journal-title":"Kidney Int"},{"key":"jrv240021r75","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1294064","article-title":"Oral nutritional supplement helps to improve nutritional status of dialysis dependent patients: a systematic review and meta-analysis of randomized controlled trials.","volume":"10","author":"Ren","year":"2023","journal-title":"Frontiers Nutr"},{"key":"jrv240021r76","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2147\/TCRM.S171970","article-title":"Risk of hip fracture in patients on dialysis or kidney transplant: a meta-analysis of 14 cohort studies.","volume":"14","author":"Tan","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"jrv240021r77","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49636","article-title":"Mortality after hip and spine fractures in patients with end-stage kidney disease: a systematic review and meta-analysis.","volume":"15","author":"Shimamura","year":"2023","journal-title":"Cureus"},{"issue":"8","key":"jrv240021r78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006023.pub3","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"8","author":"Ruospo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"jrv240021r79","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1159\/000530230","article-title":"Real-world phosphate binder use among dialysis-dependent patients with CKD.","volume":"147","author":"Berner","year":"2023","journal-title":"Nephron"},{"issue":"3","key":"jrv240021r80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2020.02.439","article-title":"Comparative effectiveness of calcimimetic agents for secondary hyperparathyroidism in adults: a systematic review and network meta-analysis.","volume":"76","author":"Palmer","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"jrv240021r81","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1053\/j.ajkd.2023.04.003","article-title":"Vitamin D therapy in adults with CKD: a systematic review and meta-analysis.","volume":"82","author":"Yeung","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv240021r82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2015.04.046","article-title":"Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.","volume":"199","author":"Oltmann","year":"2015","journal-title":"J Surg Res"},{"issue":"8","key":"jrv240021r83","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1681\/ASN.2013060601","article-title":"Assessment and management of hypertension in patients on dialysis.","volume":"25","author":"Agarwal","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"jrv240021r84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1681\/ASN.0000000000000315","article-title":"Resistant hypertension in dialysis: epidemiology, diagnosis, and management.","volume":"35","author":"Georgianos","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"jrv240021r85","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines.","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"9668","key":"jrv240021r86","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","article-title":"Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.","volume":"373","author":"Heerspink","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"jrv240021r87","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.2215\/CJN.02250507","article-title":"Home blood pressures are of greater prognostic value than hemodialysis unit recordings.","volume":"2","author":"Alborzi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"jrv240021r88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010070.pub3","article-title":"Altered dietary salt intake for people with chronic kidney disease.","volume":"6","author":"McMahon","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"jrv240021r89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011204.pub2","article-title":"Low dialysate sodium levels for chronic haemodialysis.","volume":"1","author":"Dunlop","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv240021r90","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.108.125674","article-title":"Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"jrv240021r91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.ajkd.2019.07.025","article-title":"Lung ultrasound-guided dry weight assessment and echocardiographic measures in hypertensive hemodialysis patients: a randomized controlled study.","volume":"75","author":"Loutradis","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"jrv240021r92","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231185433","article-title":"Bioimpedance-guided monitoring of volume status in patients with kidney disease: a systematic review and meta-analysis.","volume":"10","author":"Horowitz","year":"2023","journal-title":"Can J Kidney Health Dis"},{"issue":"3","key":"jrv240021r93","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"jrv240021r94","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","article-title":"Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients.","volume":"23","author":"Tepel","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"jrv240021r95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013109.pub2","article-title":"Aldosterone antagonists for people with chronic kidney disease requiring dialysis.","volume":"2","author":"Hasegawa","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"jrv240021r96","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"jrv240021r97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004289.pub5","article-title":"HMG CoA reductase inhibitors (statins) for dialysis patients.","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv240021r98","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40620-020-00707-2","article-title":"Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology.","volume":"33","author":"Pontremoli","year":"2020","journal-title":"J Nephrol"},{"issue":"23","key":"jrv240021r99","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients.","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"jrv240021r100","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.hrthm.2014.03.041","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.","volume":"11","author":"Kusumoto","year":"2014","journal-title":"Heart Rhythm"},{"issue":"4","key":"jrv240021r101","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2215\/CJN.10510917","article-title":"Recommendations for the care of patients receiving conservative kidney management: focus on management of CKD and symptoms.","volume":"14","author":"Davison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"jrv240021r102","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus.","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"jrv240021r103","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jamainternmed.2023.2215","article-title":"Effects of technology assisted stepped collaborative care intervention to improve symptoms in patients undergoing hemodialysis: The TACcare Randomized Clinical Trial.","volume":"183","author":"Jhamb","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"6","key":"jrv240021r104","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M18-2229","article-title":"Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial.","volume":"170","author":"Mehrotra","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"jrv240021r105","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2013.252","article-title":"Worldwide, mortality risk is high soon after initiation of hemodialysis.","volume":"85","author":"Robinson","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"jrv240021r106","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2019.01.017","article-title":"Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"96","author":"Chan","year":"2019","journal-title":"Kidney Int"},{"issue":"3","key":"jrv240021r108","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1148\/radiol.2019192094","article-title":"Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation.","volume":"294","author":"Davenport","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"jrv240021r109","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update.","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"jrv240021r110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.15585\/mmwr.mm7301a3","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older\u2014United States, 2024.","volume":"73","author":"Murthy","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"jrv240021r3","volume-title":"2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","author":"United States Renal Data System (USRDS)","year":"2023"},{"key":"jrv240021r31","unstructured":"Canadian Agency for Drugs and Technologies in Health. Dialysis modalities for the treatment of end-stage kidney disease: recommendations. Published online March 2017. Accessed July 26, 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/30234935\/"},{"key":"jrv240021r69","unstructured":"The DOPPS Practice Monitor. Mineral and bone disorder. 2024. Accessed May 27, 2024. https:\/\/www.dopps.org\/DPM-HD\/DPMSlideBrowser.aspx"},{"key":"jrv240021r107","unstructured":"DialysisData. Stakeholder feedback for the ESRD Patient Life Goals Survey (PaLS). 2024. Accessed May 27, 2024. https:\/\/dialysisdata.org\/content\/esrd-measures"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2824363\/jama_flythe_2024_rv_240021_1730922277.20624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T11:02:18Z","timestamp":1731409338000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2824363"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":110,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,11,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.16338","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}